Ukuhlola i-Avastin Nemiphumela Yayo Emibi
I-Avastin (bevacizumab) iyisidakamizwa esibheka uhlobo lweprotheyini (i-VEGF) ekhona kwamathumba amaningi e- colon . Ngokwenza kanjalo, kusiza ukuvimbela izicubu ukuba zisakaze kwezinye izindawo emzimbeni ( imetastasizing ).
Olunye ucwaningo lubonise ukuthi ukwengeza i-Avastin emgomweni we-chemotherapy kungasiza abantu abanomdlavuza ohamba phambili abaphila isikhathi eside. Kodwa-ke, umkhiqizi ka-Avastin uye wakhipha izixwayiso mayelana nezingozi ezithile ezihlobene nomuthi, futhi isifundo eshicilelwe ku- Annals of Pharmacotherapy sabika enye imiphumela engase ibe khona - ukuhluleka kwezinso.
Imininingwane yeSifundo
Kubalulekile ukuqaphela ukuthi lolu cwaningo lwaluyimbiko yecala, okusho ukuthi likhuluma ngomuntu oyedwa. Ngokucacile, owesilisa oneminyaka engu-26 ubudala onesifo se- leiomyosarcoma (uhlobo olungavamile lomdlavuza omncane) wahlaselwa yizinso ngenkathi ephathwa no-Avastin nabacwaningi banquma ukuthi i-Avastin ibangele.
Imiphumela yalesi sihloko asikhombisi ukuthi abantu abathatha i-Avastin kudingeka bakhathazeke ngokuthuthukisa ukwehluleka kwezinso. Ngidlulisa lolu lwazi kanye kuphela uma kwenzeka umuntu othakazelisa i-Avastin izibonakaliso zokuhluleka kwezinso, ngakho-ke bangakwazi ukubeka ndawonye kabili. Izimpawu zingabandakanya ukugcinwa oketshezi, umfutho wegazi ophezulu, ukushaya kwenhliziyo okungavamile, ukuxubha kwemisipha, nokuqothulwa.
Ukucwaninga okuhlobene okuhambisanayo
- I-Avastin Ivumela Ukukhula Kwegciwane LeColon
- FOLFOX4 Plus Avastin: Kufanele Uzame?
- Ingabe i-FOLFOX4 ngawe?
- I-FOLFOX4 I-Drug Combo Evezwe Ngempumelelo
Ezinye zokwelapha zeCrorectrect Cancer
Ngaphandle kwe-Avastin, umuthi ohlose ngokuqondile umdlavuza we-colorectal, kunezinye izindlela zokwelashwa ezitholakalayo kule sifo.
Inothi, ukwelashwa okuqondile kwezifo ezinamabala kakhulu kuncike ebukhulu besigaba.
Nanka ezinye zezindlela okubhekwa ngayo ukudweba:
- ukususwa okuhlinzekwayo (ukuguqulwa) kwe-tumor, ingxenye ethintekile yesiguli, ukukhipha izitho zamagciwane kanye nezingxenye zamalungu anamathiselwe;
- ukwelapha okusebenzayo noma i-chemotherapy, kuhlanganise nezidakamizwa ezinjenge-5-FU, capecitabine, ne leucovorin;
- i-radiotherapy kubantu abanekhanda lomhlanga;
- ukubhekwa njalo emva kokuhlinzwa, i-chemotherapy, kanye nezinye izindlela zokungenelela ukuqinisekisa ukuthi umdlavuza awubuyanga.
Ngenhlanhla, phakathi neminyaka engama-30 edlule, ukuqonda kwethu umdlavuza we-colorectal kuye kwathuthuka. Manje sisazi okuningi mayelana nale pathogenesis yomdlavuza, izimbangela zayo, kanye nezici ezingenzeka zibe yingozi. Ngaphezu kwalokho, manje sesiyaqonda kangcono indlela yokuhlola lesi sifo futhi sigweme ukugula okungathí sina. Ngaphezu kwalokho, isixuku sezidakamizwa sisempayipi ukuphatha izigaba zangaphambili zalesi sifo, futhi izindlela ezihlukahlukene zokufundisa zithuthukisa ukwelashwa kwalesi sifo. Ebheke phambili, ochwepheshe banethemba lokuthi ukwelashwa kwalesi sifo esibulalayo kuzokwenza ngcono kuphela. Noma kunjalo, indlela engcono kakhulu yokubhekana nomdlavuza wokugqama ukuwubamba ngokushesha usebenzisa izindlela zokuhlola ezifana ne-colonoscopy.
Umthombo: uBarakat, R. no-Singh, uN. "Isikhungo seNepritis Secondary kuya kweBeciciumumab Treatment ku-Metastatic Leiomyosarcoma." I-Annals of Pharmacotherapy 41.4 (2007): 707-710. Ifinyelele ngomhla ka-21 Ephreli 2007.